P

Inventor

REIMER ULF

DE13 patents
⚠️ This page may combine multiple inventors who share the name “REIMER ULF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SHIRE ORPHAN THERAPIES GMBH

5 patents
US9169293B2Oct 27, 2015

NPR-B agonists

SHIRE ORPHAN THERAPIES GMBH4 citations81
US9745344B2Aug 29, 2017

NPR-B agonists

SHIRE ORPHAN THERAPIES GMBH3 citations70
US9982016B2May 29, 2018

NPR-B agonists

SHIRE ORPHAN THERAPIES GMBH1 citations60
US9458198B1Oct 4, 2016

Cyclic peptide-based NPR-B agonists

SHIRE ORPHAN THERAPIES GMBH2 citations60
US10196423B2Feb 5, 2019

NPR-B agonists

SHIRE ORPHAN THERAPIES GMBH0 citations48

Baxalta GmbH

2 patents
US11001613B2May 11, 2021

TFPI inhibitors and methods of use

Baxalta GmbH1 citations62
US9777051B2Oct 3, 2017

TFPI inhibitors and methods of use

Baxalta GmbH1 citations62

DOCKAL MICHAEL

1 patent
US8466108B2Jun 18, 2013

TFPI inhibitors and methods of use

DOCKAL MICHAEL10 citations83

OSTERKAMP FRANK

1 patent
US8546523B2Oct 1, 2013

NPR-B agonists

OSTERKAMP FRANK7 citations78

BioNTech SE

1 patent
US11046745B2Jun 29, 2021

Peptide mimotopes of the CD3 T-cell co-receptor epsilon chain and uses thereof

BioNTech SE3 citations68

BIONTECH AG

1 patent
US10858415B2Dec 8, 2020

Peptide mimotopes of claudin 18.2 and uses thereof

BIONTECH AG1 citations57

JPT PEPTIDE TECHNOLOGIES GMBH

1 patent
US8029979B2Oct 4, 2011

Method for determining the substrate specificity of an enzyme

JPT PEPTIDE TECHNOLOGIES GMBH5 citations49

GIBSON CHRISTOPH

1 patent
US8410134B2Apr 2, 2013

8-oxy-quinoline derivatives as bradykinin B2 receptor modulators

GIBSON CHRISTOPH1 citations41